Amwell lowers 2023 revenue outlook, racks up impairment charge in Q2
The telehealth company’s results are being impacted by churn on Amwell’s legacy platform as it migrates customers to its Converge software, CFO Robert Shepardson said.
The telehealth company’s results are being impacted by churn on Amwell’s legacy platform as it migrates customers to its Converge software, CFO Robert Shepardson said.